Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC
Clinical trial NCT05243355 · UNKNOWN
Trial details
- NCT number
- NCT05243355
- Sponsor
- Qilu Hospital of Shandong University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-12-03
- Primary completion
- 2023-12-03
- Enrollment
- 46
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.